Clinical Trial Update: Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy

View source ↗

Summary

Pfizer-sponsored observational cohort study in Italy evaluating anti-TNF therapy for Ankylosing Spondylitis; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Assial

Snippet

Sponsor: Pfizer | Conditions: Ankylosing Spondylitis | Status: COMPLETED | Results posted: 2017-03-09